Pharmavite will leverage its quality-driven, science-based capabilities and applications expertise to formulate the newly discovered bioactive peptides into consumer dose forms and validate the efficacy of these new discoveries within clinical trials
Nuritas and Pharmavite LLC, U.S. manufacturer of high-quality vitamins, minerals and supplements, have entered into a Discovery and Option agreement aimed at discovering bioactive peptide networks to address one of the 21stCentury’s biggest health and wellness concerns and meet a target of huge consumer demand.
In order to achieve the common goal, Nuritas will deploy its proven technology platform, which combines Artificial Intelligence and DNA analysis to predict, unlock, and validate bioactive peptide ingredients. Pharmavite will leverage its quality-driven, science-based capabilities and applications expertise to formulate the newly discovered bioactive peptides into consumer dose forms and validate the efficacy of these new discoveries within clinical trials.
Neil Foster, Head of Strategic Partnerships, Nuritas said, “As consumer preference and healthcare necessity switches attention from treatment to prevention, nutritional supplements and functional foods plays a key role in the Nuritas Consumer strategy. Consumers are increasingly seeking natural products but with the highest possible levels of scientific evidence to support their efficacy.”
Dr. Susan Hazels Mitmesser, Vice President of Science and Technology said, “At Pharmavite, we’re committed to improving people’s lives and their nutritional status by raising the bar in scientific research, innovation and product development. We’re excited to partner with Nuritas to develop targeted nutritional solutions that deliver experiential benefits via the Artificial Intelligence and DNA analysis technology.”
Dr. Chioma Ikonte, Director of Nutrition Sciences at Pharmavite said, “Our purpose of bringing the gift of health to life is the foundation for our science-based approach. As a leader in supplemental nutrition, our partnership with Nuritas will enable us to deliver innovative solutions that help people live healthier, more vital lives.”
Emmet Browne, CEO at Nuritas said, “We are delighted to be collaborating with Pharmavite, who continues to lead the industry in providing trusted, high-quality supplemental nutrition through their Nature Made brand. This partnership aligns perfectly with our mission to positively impact billions of lives worldwide.”
Founded in 2014 by mathematician and bioinformatician Dr. Nora Khaldi, Nuritas is a discovery platform for active peptides that can prevent or treat disease with industry leading speed and accuracy.